XBIOTECH INC (XBIT) Stock Balance Sheet
NASDAQ:XBIT - Nasdaq - CA98400H1029 - Common Stock - Currency: USD
| MRQ (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 188.53M | 200.02M | 157.30M | 237.00M | 237.40M | |||
| Marketable Securities | N/A | 0.00 | 60.20M | N/A | N/A | |||
| Receivables | 993.00K | 935.00K | 1.80M | 9.00M | 85.80M | |||
| Other Current Assets | 1.12M | 760.00K | 600.00K | 900.00K | 2.80M | |||
| Total Current Assets | 190.64M | 201.72M | 219.80M | 246.90M | 325.90M | |||
| Non-Current Assets | ||||||||
| PPE Net | 24.92M | 24.90M | 26.30M | 28.30M | 27.30M | |||
| Other Non-Current Assets | N/A | N/A | N/A | 0.00 | 500.00K | |||
| Total Non-Current Assets | 24.92M | 24.90M | 26.30M | 28.30M | 27.80M | |||
| TOTAL ASSETS | 215.56M | 226.62M | 246.10M | 275.20M | 353.70M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 10.00M | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 5.35M | 3.50M | 1.60M | 1.40M | 1.40M | |||
| Accounts Payable | 1.70M | 2.52M | 2.40M | 2.10M | 2.50M | |||
| Other Current Liabilities | 83.00K | 83.00K | 100.00K | 0.00 | 100.00K | |||
| Total Current Liabilities | 17.14M | 6.10M | 4.10M | 3.50M | 4.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | N/A | 0.00 | 100.00K | 900.00K | N/A | |||
| Other Non-Current Liabilities | 1.72M | 1.67M | 1.60M | 1.50M | 1.10M | |||
| Total Non-Current Liabilities | 1.72M | 1.67M | 1.60M | 2.30M | 1.10M | |||
| TOTAL LIABILITIES | 18.85M | 7.77M | 5.70M | 5.80M | 5.10M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -75.31M | -52.31M | -27.70M | 5.20M | 97.60M | |||
| Common Shares | 272.01M | 271.15M | 267.30M | 262.30M | 249.80M | |||
| Other Shareholders' Equity | N/A | 0.00 | 800.00K | 2.00M | 1.30M | |||
| Shares Outstanding | 30.46M | 30.44M | 30.40M | 30.40M | 29.30M | |||
| Tangible Book Value per Share | 6.46 | 7.19 | 7.91 | 8.86 | 11.90 | |||
| Total Shareholders' Equity | 196.70M | 218.85M | 240.40M | 269.40M | 348.60M | |||
| TOTAL LIABILITIES AND EQUITY | 215.56M | 226.62M | 246.10M | 275.20M | 353.70M | |||
| Statistics | ||||||||
| Current Ratio | 11.13 | 33.07 | 53.61 | 70.54 | 81.47 | |||
| Return On Assets (ROA) | -16.24% | -10.84% | -13.37% | -6.33% | -3.17% | |||
| Return On Equity (ROE) | -17.80% | -11.22% | -13.69% | -6.46% | -3.22% | |||
All data in USD , ROIC based on taxRate of 0.21